In vitro diagnostic medical devices (IVDs) are often used in combination with other devices and equipment, and this needs to be planned and managed carefully so that the combination does not impair the performance of any of the individual devices, according to a Medicines and Healthcare products Regulatory Agency (MHRA) bulletin issued recently.
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
Royal Air Force Museum, Hendon, London
21 May, 2026
Sheffield Hallam University Atrium Conference Centre, Sheffield S1 1WB
3-4 June, 2026
The Eastside Rooms conference centre, Birmingham
8-10 June, 2026
Excel, London
9-10 June, 2026
St Andrew’s Stadium, Birmingham
11th June 2026
